Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Should everyone over 50 be taking aspirin?

17.06.2005


For and against: Aspirin for everyone over 50? BMJ Volume 330, pp 1440-3



Experts go head to head in this week’s BMJ over whether everyone over 50 should take a daily aspirin to reduce their risk of heart attacks and strokes. Peter Elwood and colleagues at Cardiff University believe that the evidence now supports more widespread use of aspirin, and there needs to be a strategy to inform the public and enable older people to make their own decision.

As a general rule, daily aspirin is given only to people whose five year risk of a vascular event, such as a heart attack or stroke, is 3% or more. The authors show that, by age 50, 80% of men and 50% of women reach this level of risk and they suggest that 90-95% of the population could take low dose aspirin without problems. Evidence is also growing that regular aspirin may reduce cancer and dementia.


"The possibility that a simple, daily, inexpensive low dose pill would achieve a reduction in vascular events, and might achieve reductions in cancer and dementia without the need for screening, deserves serious consideration," they write. "Although we judge that aspirin should be taken from around 50 years, we insist that the general public should be well informed and the final decision should lie with each person."

But Colin Baigent of the Oxford Radcliffe Infirmary warns that it would be unwise to adopt such a policy, whatever age threshold is chosen, until we are sure that older patients will derive net benefit from it.

Based on data for 55-59 year olds, aspirin prevents around two first heart attacks per 1000 population each year. However, this benefit does not outweigh the expected risk of a major gastrointestinal bleed at age 60 (1-2 per 1000 per year).

"In my view, we should not contemplate an age threshold approach to primary prevention with aspirin until we have much better evidence of its benefits in older people," he says. We therefore need further randomised trials comparing low dose aspirin with placebo.

"A recommendation that aspirin be used for primary prevention of vascular disease in unselected people over a certain age could result in net harm, and we must have very good evidence to the contrary before instituting such a policy," he concludes.

Emma Dickinson | EurekAlert!
Further information:
http://www.bmj.com

More articles from Health and Medicine:

nachricht Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University

nachricht Spread of deadly eye cancer halted in cells and animals
13.11.2018 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

Im Focus: Coping with errors in the quantum age

Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly

The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Massive impact crater from a kilometer-wide iron meteorite discovered in Greenland

15.11.2018 | Earth Sciences

When electric fields make spins swirl

15.11.2018 | Physics and Astronomy

Discovery of a cool super-Earth

15.11.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>